Impact of Methicillin-Resistance on Mortality in Children and Neonates with Staphylococcus aureus Bacteremia: A Meta-analysis
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: Staphylococcus aureus bacteremia (SAB) is the Staphylococcal infections in blood, one of the most common and fatal bacterial infectious diseases worldwide in adults as well as children or neonates. Recently, some studies have yielded inconsistent findings about the association between methicillin-resistance and mortality in patients with SAB. We performed a meta-analysis to assess the impact of methicillin-resistance on mortality in children or neonates with S. aureus bacteremia. Materials and Methods: We searched using electronic databases such as Ovid-Medline, EMBASE-Medline, and Cochrane Library, as well as five local databases for published studies during the period of 1 January 2000 to 15 September 2011. Two reviewers independently selected articles in accordance with predetermined criteria and extracted prespecified data based on standardized forms. All cohort studies, which compared in-hospital mortality or SAB-related mortality in children and neonates with methicillin-resistant S. aureus (MRSA) infection to those with methicillin-susceptible S. aureus (MSSA), were included. We conducted meta-analysis using the fixed-effect model to obtain pooled estimates of effect. Results: Of 2,841 screened studies, seven cohort studies were finally selected for analysis. In children or neonates, MRSA bacteremia was associated with a higher mortality compared with MSSA bacteremia (pooled odds ratio [OR] 2.33, P = 0.0008, 95% confidence interval [CI] 1.42 to 3.82, I2 = 0%). Four studies reported SAB-related mortality, the pooled OR of these studies was 2.03 ( P = 0.29,95% CI 0.55 to 7.53, I2 = 0%). A significant increase in mortality associated with methicillin resistance was found in the subgroup analyses of the studies with only neonates (OR: 2.66, 95% CI: 1.46 to 4.85, P = 0.001), prospectively design ones (OR: 3.20, 95% CI:1.66 to 6.15, P = 0.0005,), the larger studies (OR: 2.89, 95% CI: 1.62 to 5.16, P = 0.0003) and the higher quality studies (OR: 2.76,95% CI: 1.50 to 5.06, P = 0.001). Conclusions: MRSA bacteremia is associated with increased mortality compared with MSSA bacteremia in children or neonates. Due to limited studies for mortality in children or neonates with SAB, further research is needed to evaluate the impact of methicillin resistance on mortality in those populations.
Abstract
Background: Staphylococcus aureus bacteremia (SAB) is the Staphylococcal infections in blood, one of the most common and fatal bacterial infectious diseases worldwide in adults as well as children or neonates. Recently, some studies have yielded inconsistent findings about the association between methicillin-resistance and mortality in patients with SAB. We performed a meta-analysis to assess the impact of methicillin-resistance on mortality in children or neonates with S. aureus bacteremia. Materials and Methods: We searched using electronic databases such as Ovid-Medline, EMBASE-Medline, and Cochrane Library, as well as five local databases for published studies during the period of 1 January 2000 to 15 September 2011. Two reviewers independently selected articles in accordance with predetermined criteria and extracted prespecified data based on standardized forms. All cohort studies, which compared in-hospital mortality or SAB-related mortality in children and neonates with methicillin-resistant S. aureus (MRSA) infection to those with methicillin-susceptible S. aureus (MSSA), were included. We conducted meta-analysis using the fixed-effect model to obtain pooled estimates of effect. Results: Of 2,841 screened studies, seven cohort studies were finally selected for analysis. In children or neonates, MRSA bacteremia was associated with a higher mortality compared with MSSA bacteremia (pooled odds ratio [OR] 2.33, P = 0.0008, 95% confidence interval [CI] 1.42 to 3.82, I2 = 0%). Four studies reported SAB-related mortality, the pooled OR of these studies was 2.03 ( P = 0.29,95% CI 0.55 to 7.53, I2 = 0%). A significant increase in mortality associated with methicillin resistance was found in the subgroup analyses of the studies with only neonates (OR: 2.66, 95% CI: 1.46 to 4.85, P = 0.001), prospectively design ones (OR: 3.20, 95% CI:1.66 to 6.15, P = 0.0005,), the larger studies (OR: 2.89, 95% CI: 1.62 to 5.16, P = 0.0003) and the higher quality studies (OR: 2.76,95% CI: 1.50 to 5.06, P = 0.001). Conclusions: MRSA bacteremia is associated with increased mortality compared with MSSA bacteremia in children or neonates. Due to limited studies for mortality in children or neonates with SAB, further research is needed to evaluate the impact of methicillin resistance on mortality in those populations.
참고문헌 (26)
- Laupland KB, "Population-based study of the epidemiologyof and the risk factors for invasive Staphylococcus aureusinfections", J Infect Dis, 187, pp.1452~1459 (2003)
- Brumfitt W, "The worldwide problemof methicillin-resistant Staphylococcus aureus", Drugs ExpClin Res, 16, pp.205~214 (1990)
- Naimi TS, "Comparison of community-and health care-associated methicillin-resistantStaphylococcus aureus infection", JAMA, 290, pp.2976~2984 (2003)
- Kaech C, "Course and outcome of Staphylococcus aureusbacteremia: a retrospective analysis of 308 episodes in aSwiss ter tiary-care centre", Clin Microbiol Infect, 12, pp.345~352 (2006)
- Kern WV, "Management of Staphylococcus aureus bacteremiaand endocarditis: progress and challenges", Curr OpinInfect Dis, 23, pp.346~358 (2010)
- Whitby M, "Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: ameta-analysis", Med J Aust, 175, pp.264~267 (2001)
- Cosgrove SE, "Comparison of mortality associatedwith methicillin-resistant and methicillin-susceptibleStaphylococcus aureus bacteremia: a meta-analysis", ClinInfect Dis, 36, pp.53~59 (2003)
- Herold BC, "Community-acquired methicillin-resistant Staphylococcus aureusin children with no identified predisposing risk", JAMA, 279, pp.593~598 (1998)
- Khairulddin N, "Emergence of methicillin resistant Staphylococcusaureus (MRSA) bacteraemia among children in Englandand Wales, 1990-2001", Arch Dis Child, 89, pp.378~379 (2004)
- Chuang YY, "Chou YH.Methicillin-resistant Staphylococcus aureus bacteraemiain neonatal intensive care units: an analysis of 90 episodes", Acta Paediatr, 93, pp.786~790 (2004)
- Purcell K, "Epidemic of community-acquiredmethicillin-resistant Staphylococcus aureus infections: a14-year study at Driscoll Children’s Hospital", Arch PediatrAdolesc Med, 159, pp.980~985 (2005)
- Hakim H, "Morbidity and mortality of Staphylococcal bacteremia in children", Am J InfectControl, 35, pp.102~105 (2007)
- Burke RE, "Pediatricand neonatal Staphylococcus aureus bacteremia: epidemiology,risk factors, and outcome", Infect Control HospEpidemiol, 30, pp.636~644 (2009)
- Isaacs D, "Staphylococcus aureusinfections in Australasian neonatal nurseries", Arch DisChild Fetal Neonatal Ed, 89, pp.F331~F335 (2004)
- Kuint J, "Comparison of community-acquiredmethicillin-resistant Staphylococcus aureus bacteremia toother staphylococcal species in a neonatal intensive careunit", Eur J Pediatr, 166, pp.319~325 (2007)
- DerSimonian R, "Meta-analysis in clinical trials", Control Clin Trials, 7, pp.177~188 (1986)
- "The Newcastle-Ottawa Scale (NOS) for assessingthe quality if nonrandomized studies in metaanalyses"[URL]
- Higgins JP, "Measuringinconsistency in meta-analyses", BMJ, 327, pp.557~560 (2003)
- Hogg RV, "Probability and Statistical Inference" (1988), Macmillan
- Egger M, "Bias inmeta-analysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
- Begg CB, "Operating characteristics of arank correlation test for publication bias", Biometrics, 50, pp.1088~1101 (1994)
- Hulten KG, "Hospital-acquired Staphylococcus aureus infectionsat Texas Children’s Hospital, 2001-2007", InfectControl Hosp Epidemiol, 31, pp.183~190 (2010)
- Kayange N, "Predictors of positive blood culture anddeaths among neonates with suspected neonatal sepsis ina tertiary hospital, Mwanza-Tanzania", BMC Pediatr, 10, pp.39~ (2010)
- Kang HC, "Staphylococcal infection in the neonatal intensive care unit", J Korean Soc Neonatol, 14, pp.215~220 (2007)
- Easterbrook PJ, "Publicationbias in clinical research", Lancet, 337, pp.867~872 (1991)